Clinical Trials Directory

Trials / Sponsors / Quantum Genomics SA

Quantum Genomics SA

Industry · 10 registered clinical trials.

StatusTrialPhaseStarted
TerminatedRandomized Study of Extended Treatment With Firibastat in Treatment-Resistant Hypertension (REFRESH)
Hypertension (HTN)
Phase 32021-08-05
CompletedFiribastat in Treatment-resistant Hypertension
Hypertension
Phase 32020-06-25
CompletedPharmacokinetics in End Stage Renal Disease Patients
Healthy Volunteers, Renal Failure
Phase 12019-09-17
CompletedFiribastat or Ramipril After Acute Myocardial Infarction for Prevention of Left Ventricular Dysfunction
Myocardial Infarction
Phase 22019-06-04
CompletedEvaluation of the PK Profile of Firibastat Following Administration of Firibastat Prototype Tablet Formulation
Healthy Males
Phase 12019-02-15
CompletedNovel Evaluation With QGC001 in Hypertensive Overweight Patients of Multiple Ethnic Origins
Hypertension
Phase 22017-10-13
TerminatedQUantum Genomics Incremental Dosing in Heart Failure - QUID-HF
Heart Failure
Phase 22016-06-01
CompletedPhase IIa Study of the Product QGC001 Compared With Placebo in Patients With Essential Hypertension
Essential Hypertension
Phase 22015-01-01
CompletedStudy of the Product QGC001 as a Single Dose and Multiple Doses Administered Orally to Healthy Adult Subjects
Essential Hypertension
Phase 12012-12-01
CompletedPhase I Study in Healthy Male Subjects Comparing QGC001 to Placebo
Essential Hypertension
Phase 12012-02-01